Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | PRKDC | P78527 | 4/20 | 0.37 |
| ▸ | F9 | P00740 | 1/20 | 0.37 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.35 |
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.34 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.33 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16883099 | 0.99 | ALOX5 (0.47) | ALOX5PRKDCF9PARP14TNKS | |
| SCHEMBL16883109 | 0.96 | ALOX5 (0.47) | ALOX5PRKDCF9PARP14TNKS | |
| SCHEMBL26336309 | 0.93 | ALOX5 (0.44) | ALOX5PRKDCF9PARP14TNKS | |
| SCHEMBL26056752 | 0.92 | ALOX5 (0.44) | ALOX5PRKDCF9PARP14TNKS | |
| SCHEMBL22136359 | 0.92 | ALOX5 (0.48) | ALOX5PRKDCF9PARP14TNKS | |
| SCHEMBL16883147 | 0.92 | ALOX5 (0.45) | ALOX5PRKDCF9PARP14TNKS | |
| SCHEMBL24888037 | 0.92 | ALOX5 (0.45) | ALOX5PRKDCF9PARP14TNKS | |
| SCHEMBL18212056 | 0.92 | ALOX5 (0.47) | ALOX5PRKDCF9PARP14TNKS | |
| SCHEMBL16883139 | 0.91 | ALOX5 (0.51) | ALOX5PRKDCF9PARP14TNKS | |
| SCHEMBL16883089 | 0.91 | ALOX5 (0.51) | ALOX5PRKDCF9PARP14TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10985325-B2 | Aromatic amine derivative, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2021-04-20 | — | — | US | disclosed |
| EP-3312167-A1 | AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-20150263292-A1 | AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-17 | — | — | US | disclosed |
| US-20150263292-A1 | AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-17 | — | — | US | disclosed |
| EP-2891653-A1 | AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | Idemitsu Kosan Co., Ltd (JP) | 2015-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150263292-A1 | AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | RER1, H1-2, NAP1L1 | ALOX5 2443/4885PRKDC 4736/4885F9 4636/4885 |
| US-10985325-B2 | Aromatic amine derivative, and organic electroluminescent element using same | RER1, H1-2, NAP1L1 | ALOX5 2443/4885PRKDC 4736/4885F9 4636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.